Author | Melissa Burgess, MD | OncLive

Author | Melissa Burgess, MD

Articles

Dr. Burgess on Pembrolizumab in Sarcoma

January 17, 2017

Video

In the phase II SARC028 trial, single-agent pembrolizumab (Keytruda) demonstrated antitumor activity in patients with advanced soft tissue and bone sarcomas.

x